
BVNRY
Healthcare · Biotechnology · $2.61B market cap
$11.64-0.17 (-1.4%)Nov 13, 9:36 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2025 | Before the open | — | 0.73 | — |
| Aug 12, 2025 | Before the open | — | 0.24 | — |
| May 6, 2025 | Before the open | — | 0.13 | — |
| Mar 5, 2025 | Before the open | — | 0.47 | — |
| Nov 15, 2024 | Before the open | — | 0.04 | — |
| Aug 22, 2024 | Before the open | — | 0.16 | — |
| May 8, 2024 | Before the open | — | -0.07 | — |
| Mar 6, 2024 | Before the open | — | 0.56 | — |
| Sep 30, 2021 | Time not confirmed | — | -0.20 | — |
| Jun 30, 2021 | Time not confirmed | — | -0.38 | — |
| Mar 31, 2021 | Time not confirmed | — | -0.35 | — |
| Dec 31, 2020 | Time not confirmed | — | -1.06 | — |
| Aug 25, 2020 | After the close | -1.76 | 2.20 | +225.0% |
| May 13, 2020 |
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for…
| After the close |
| 11.30 |
| 12.60 |
| +11.5% |
| Feb 19, 2020 | After the close | -1.27 | -1.40 | -10.2% |
| Nov 7, 2019 | Time not confirmed | -2.84 | -3.10 | -9.2% |
| Aug 14, 2019 | After the close | -2.46 | -3.20 | -30.1% |
| May 21, 2019 | After the close | -2.86 | -3.10 | -8.4% |
| Mar 20, 2019 | After the close | -0.42 | -3.14 | -647.6% |
| Nov 8, 2018 | After the close | -2.50 | 1.00 | +140.0% |
| Aug 15, 2018 | After the close | -4.11 | -3.40 | +17.3% |
| May 23, 2018 | After the close | -4.41 | -5.70 | -29.3% |
| Mar 11, 2018 | After the close | -3.72 | -5.70 | -53.2% |